Clopidogrel pathway. [Pharmacogenet Genomics. 2010] - PubMed

loading

In brief: poor metabolizers of clopidogrel (plavix). [Med Lett Drugs Ther. 2010]
In brief: poor metabolizers of clopidogrel (plavix).
[No authors listed]Med Lett Drugs Ther. 2010 May 3; 52(1337):33.
Platelet aggregation pathway. [Pharmacogenet Genomics. 2011]
Platelet aggregation pathway.
Sangkuhl K, Shuldiner AR, Klein TE, Altman RB. Pharmacogenet Genomics. 2011 Aug; 21(8):516-21.
Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition. [Drug Metab Lett. 2009]
Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition.
Zhang H, Ragueneau-Majlessi I, Levy RH. Drug Metab Lett. 2009 Dec; 3(4):287-9.
Review Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. [J Clin Pharmacol. 2010]
Review Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.
Farid NA, Kurihara A, Wrighton SA. J Clin Pharmacol. 2010 Feb; 50(2):126-42. Epub 2009 Nov 30.
Review Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4. [Pharm Res. 2006]
Review Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4.
Lau WC, Gurbel PA. Pharm Res. 2006 Dec; 23(12):2691-708. Epub 2006 Oct 24.

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. [Pharmacogenet Genomics. 2012]
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.
Scott SA, Sangkuhl K, Shuldiner AR, Hulot JS, Thorn CF, Altman RB, Klein TE. Pharmacogenet Genomics. 2012 Feb; 22(2):159-65.
Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions. [Clin Pharmacol Ther. 2011]
Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.
Beitelshees AL, Horenstein RB, Vesely MR, Mehra MR, Shuldiner AR. Clin Pharmacol Ther. 2011 Mar; 89(3):455-9. Epub 2011 Jan 26.
Platelet aggregation pathway. [Pharmacogenet Genomics. 2011]
Platelet aggregation pathway.
Sangkuhl K, Shuldiner AR, Klein TE, Altman RB. Pharmacogenet Genomics. 2011 Aug; 21(8):516-21.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Clopidogrel pathway.
Clopidogrel pathway.
Pharmacogenet Genomics. 2010 Jul ;20(7):463-5. doi: 10.1097/FPC.0b013e3283385420.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed